Vanguard says RBA move is prudent, the latest broker rating changes, severe weather warning & more!

Robert Proulx of Imagion Biosystems speaks at the Switzer Small and Micro Cap Investor Strategy Day September 2022.

Can October be trusted for stocks? Will it soon be buy time?

The Bank of England’s intervention by buying bonds (i.e., restarting QE) has helped calm things. Unfortunately, the return to QE may just add to inflationary pressures if it has to be sustained for long.

Donald Trump sues CNN $US475 million for defamation, Credit Suisse considers scaling back investment bank as shares drop 11%, Elon Musk receives fiery response to Ukraine war poll, and MORE.

There have always been rumours on whether mobile phones are really linked with an increased risk for brain cancer. In this week's episode, Dr Ross looks at certain studies to assess this claim.

Dr Phil Lowe has a Bud Fox moment ahead on Tuesday when he and his Board decide whether to slug us another 0.5% on our home loans.

The choppy ride in markets continues unabated, with the ASX200 losing more than 9% over the last month, but gaining over 1.4% on Thursday.

Global tightening wave ruffles feathers at RBA, economist Peter Osho says inflation better than expected, Pilbara Minerals and Lynas Rare Earths receive broker upgrades, + MORE.